Post-approval studies (Phase 4)Study completedNCT03932721
What this trial is testing
EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial
Who this might be right for
Dyslipidemia Associated With Type II Diabetes MellitusDiabetes Mellitus, Type 2Hypertension Arterial
University of Campinas, Brazil 110